Gene Therapy Led to “Robust Microdystrophin Expression” in Duchenne Muscular Dystrophy Patient
source: pixabay.com

Gene Therapy Led to “Robust Microdystrophin Expression” in Duchenne Muscular Dystrophy Patient

Duchenne muscular dystrophy (DMD) is an inherited disease that weakens a child’s muscles and eventually spreads throughout the child’s body. DMD is caused by mutations in the gene that helps…

Continue Reading Gene Therapy Led to “Robust Microdystrophin Expression” in Duchenne Muscular Dystrophy Patient
First Treatment Approved for Nonalcoholic Steatohepatitis Liver Scarring
source: shutterstock.com

First Treatment Approved for Nonalcoholic Steatohepatitis Liver Scarring

According to a press release from the US Food and Drug Administration (FDA), the agency has approved the medication resmetirom (marketed as Rezdiffra) as the first-ever treatment intended to treat…

Continue Reading First Treatment Approved for Nonalcoholic Steatohepatitis Liver Scarring
Doctors Transplant Genetically Edited Pig Kidney Into 62-Year-Old Man with End-Stage Kidney Disease
source: shutterstock.com

Doctors Transplant Genetically Edited Pig Kidney Into 62-Year-Old Man with End-Stage Kidney Disease

Over 100,000 individuals living in the U.S. are on a waiting list for an organ transplant. An average of 17 people die each day while waiting for a donor organ.…

Continue Reading Doctors Transplant Genetically Edited Pig Kidney Into 62-Year-Old Man with End-Stage Kidney Disease
Eosinophilic Esophagitis Patients Are Seeing Improved Treatment Options
Photo courtesy of Towfiqu Barbhuiya on Unsplash

Eosinophilic Esophagitis Patients Are Seeing Improved Treatment Options

Recently, the US Food and Drug Administration (FDA) approved a label expansion for the monoclonal antibody dupilumab (marketed as Dupixent) in the treatment of a rare disease called eosinophilic esophagitis…

Continue Reading Eosinophilic Esophagitis Patients Are Seeing Improved Treatment Options
ICYMI: AIT-101 Earned Orphan Drug Designation in the EU for ALS in March 2024
Capri23auto / Pixabay

ICYMI: AIT-101 Earned Orphan Drug Designation in the EU for ALS in March 2024

Historically, it has been difficult to incentivize companies to develop therapies for rare or “orphan” conditions. The National Conference of State Legislatures (NCSL) explains that “orphan” conditions are: neglected conditions…

Continue Reading ICYMI: AIT-101 Earned Orphan Drug Designation in the EU for ALS in March 2024
American College of Medical Genetics and Genomics 2024: Advances Promise a Better Future for Rare Disease Patients
source: shutterstock.com

American College of Medical Genetics and Genomics 2024: Advances Promise a Better Future for Rare Disease Patients

The overwhelming majority of rare diseases and conditions have a genetic basis. This means that the disease is the result of a genetic abnormality such as a mutation. These abnormalities…

Continue Reading American College of Medical Genetics and Genomics 2024: Advances Promise a Better Future for Rare Disease Patients
FDA Approves Tyenne, an Actemra Biosimilar for Autoinflammatory Diseases
source: shutterstock.com

FDA Approves Tyenne, an Actemra Biosimilar for Autoinflammatory Diseases

In early March 2024, Tyler Patchen reported that the U.S. Food and Drug Administration (FDA) approved both intravenous and subcutaneous formulations of Tyenne (tocilizumab-aazg) for use in a variety of…

Continue Reading FDA Approves Tyenne, an Actemra Biosimilar for Autoinflammatory Diseases
Investigational Therapy Could be Top of the Line Treatment for MASH
source: shutterstock.com

Investigational Therapy Could be Top of the Line Treatment for MASH

According to a story from Healio, encouraging results from a phase 2 trial could herald a new standard of treatment for metabolic dysfunction-associated steatohepatitis (MASH). The investigational therapy is called…

Continue Reading Investigational Therapy Could be Top of the Line Treatment for MASH
Updated ANCA-Associated Vasculitis Guidelines Aim to Improve Care
source: shutterstock.com

Updated ANCA-Associated Vasculitis Guidelines Aim to Improve Care

According to a story from Medscape, a new set of guidelines from the Kidney Disease: Improving Global Outcomes (KDIGO) aims to improve and update standards of care for antineutrophilic cytoplasmic…

Continue Reading Updated ANCA-Associated Vasculitis Guidelines Aim to Improve Care
Thalassemia and Sickle Cell Patients in the UK Gain Access to Blood Transfusion Test to Reduce Side Effects
source: pixabay.com

Thalassemia and Sickle Cell Patients in the UK Gain Access to Blood Transfusion Test to Reduce Side Effects

People living with blood disorders like sickle cell disease or thalassemia will now have access to a new blood test that will reduce transfusion side effects. England’s National Health Service…

Continue Reading Thalassemia and Sickle Cell Patients in the UK Gain Access to Blood Transfusion Test to Reduce Side Effects
Experimental Treatment Sebetralstat Shows Promise in Phase 3 HAE Study
source: shutterstock.com

Experimental Treatment Sebetralstat Shows Promise in Phase 3 HAE Study

Imagine if you had recurring attacks of severe and unexplained swelling beneath your skin. For individuals living with hereditary angioedema (HAE), a rare inherited disorder, this isn't just a mere…

Continue Reading Experimental Treatment Sebetralstat Shows Promise in Phase 3 HAE Study
Zachary Thomas Newborn Screening Act Could Introduce MPS I to Alabama’s Newborn Screening Panel
source: shutterstock.com

Zachary Thomas Newborn Screening Act Could Introduce MPS I to Alabama’s Newborn Screening Panel

Zachary Thomas has been an advocate for the mucopolysaccharidosis type I (MPS I) community since he was born.  Newborn screening is a public health initiative that tests newborn babies for…

Continue Reading Zachary Thomas Newborn Screening Act Could Introduce MPS I to Alabama’s Newborn Screening Panel
Xenotransplant: Study of Genetically Engineered Pig Kidney in the Human Body Offers Hope for Future Organ Supply
source: shutterstock.com

Xenotransplant: Study of Genetically Engineered Pig Kidney in the Human Body Offers Hope for Future Organ Supply

Out of 103,000 people in the United States waiting for a transplant, almost 88,000 individuals on the waiting list need a kidney transplant. These statistics were recently provided through Organ…

Continue Reading Xenotransplant: Study of Genetically Engineered Pig Kidney in the Human Body Offers Hope for Future Organ Supply